BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 25993466)

  • 1. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.
    Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG
    PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalable Biomimetic Coaxial Aligned Nanofiber Cardiac Patch: A Potential Model for "Clinical Trials in a Dish".
    Kumar N; Sridharan D; Palaniappan A; Dougherty JA; Czirok A; Isai DG; Mergaye M; Angelos MG; Powell HM; Khan M
    Front Bioeng Biotechnol; 2020; 8():567842. PubMed ID: 33042968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.
    Lundy SD; Zhu WZ; Regnier M; Laflamme MA
    Stem Cells Dev; 2013 Jul; 22(14):1991-2002. PubMed ID: 23461462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrospun biocomposite nanofibrous patch for cardiac tissue engineering.
    Prabhakaran MP; Kai D; Ghasemi-Mobarakeh L; Ramakrishna S
    Biomed Mater; 2011 Oct; 6(5):055001. PubMed ID: 21813957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee YK; Ng KM; Lai WH; Chan YC; Lau YM; Lian Q; Tse HF; Siu CW
    Stem Cell Rev Rep; 2011 Nov; 7(4):976-86. PubMed ID: 21614516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes.
    Uesugi M; Ojima A; Taniguchi T; Miyamoto N; Sawada K
    J Pharmacol Toxicol Methods; 2014; 69(2):177-88. PubMed ID: 24296355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of cardiac contractility modulation on human induced pluripotent stem cell-derived cardiomyocytes.
    Feaster TK; Casciola M; Narkar A; Blinova K
    Physiol Rep; 2021 Nov; 9(21):e15085. PubMed ID: 34729935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds.
    Hussain A; Collins G; Yip D; Cho CH
    Biotechnol Bioeng; 2013 Feb; 110(2):637-47. PubMed ID: 22991229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ differentiation of human-induced pluripotent stem cells into functional cardiomyocytes on a coaxial PCL-gelatin nanofibrous scaffold.
    Sridharan D; Palaniappan A; Blackstone BN; Dougherty JA; Kumar N; Seshagiri PB; Sayed N; Powell HM; Khan M
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111354. PubMed ID: 33254974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microstripe pattern substrate consisting of alternating planar and nanoprotrusive regions improved hiPSC-derived cardiomyocytes' unidirectional alignment and functional properties.
    Saotome H; Yatsuka Y; Minowa O; Shinotsuka K; Tsuchida K; Hirose H; Dai K; Tokuno H; Hayakawa T; Hiranuma H; Hasegawa A; Nakatomi I; Okazaki A; Okazaki Y
    Biomed Mater; 2024 Jun; 19(4):. PubMed ID: 38815609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes.
    Zhang JZ; Zhao SR; Tu C; Pang P; Zhang M; Wu JC
    STAR Protoc; 2021 Dec; 2(4):100859. PubMed ID: 34746854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturation of human cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) on polycaprolactone and polyurethane nanofibrous mats.
    Iwoń Z; Krogulec E; Tarnowska I; Łopianiak I; Wojasiński M; Dobrzyń A; Jastrzębska E
    Sci Rep; 2024 Jun; 14(1):12975. PubMed ID: 38839879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes.
    Schmid C; Abi-Gerges N; Leitner MG; Zellner D; Rast G
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Cryopreservation on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Assessing Drug Safety Response Profiles.
    Zhang JZ; Belbachir N; Zhang T; Liu Y; Shrestha R; Wu JC
    Stem Cell Reports; 2021 Jan; 16(1):168-181. PubMed ID: 33338435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch.
    Miyagawa S; Kawamura T; Ito E; Takeda M; Iseoka H; Yokoyama J; Harada A; Mochizuki-Oda N; Imanishi-Ochi Y; Li J; Sasai M; Kitaoka F; Nomura M; Amano N; Takahashi T; Dohi H; Morii E; Sawa Y
    Stem Cell Res Ther; 2024 Mar; 15(1):73. PubMed ID: 38475911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte-mediated electrophysiological remodeling of human stem cell - derived cardiomyocytes.
    Morrissette-McAlmon J; Xu WR; Teuben R; Boheler KR; Tung L
    J Mol Cell Cardiol; 2024 Apr; 189():52-65. PubMed ID: 38346641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates.
    Cheng YC; Hsieh ML; Lin CJ; Chang CMC; Huang CY; Puntney R; Wu Moy A; Ting CY; Herr Chan DZ; Nicholson MW; Lin PJ; Chen HC; Kim GC; Zhang J; Coonen J; Basu P; Simmons HA; Liu YW; Hacker TA; Kamp TJ; Hsieh PCH
    Circulation; 2023 Oct; 148(18):1395-1409. PubMed ID: 37732466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.